Related Experiment Videos

Intracellular killing of Brucella melitensis within mouse peritoneal macrophages: influence of treatment with

Microbiologica
|April 1, 1986
PubMed

Insights

Rifampicin damages Brucella melitensis (B. melitensis) ribosomes and cell walls. Damaged bacteria within vacuoles fuse with lysosomes in macrophages, unlike healthy bacteria.

Area of Science:

  • Microbiology
  • Cell Biology
  • Drug Discovery

Background:

  • Brucella melitensis (B. melitensis) is a facultative intracellular bacterium causing brucellosis.
  • Understanding the host-pathogen interactions and the effects of antibiotics on B. melitensis is crucial for treatment.
  • Rifampicin is a key antibiotic used against brucellosis.

Purpose of the Study:

  • To investigate the ultrastructural effects of rifampicin on B. melitensis.
  • To examine the interaction between rifampicin-treated B. melitensis and host macrophages.

Main Methods:

  • B. melitensis was cultured in Brucella-Broth medium and observed for ultrastructural changes.
  • Mouse peritoneal macrophages were infected with B. melitensis and treated with rifampicin (1 microgram/ml).
  • Transmission electron microscopy was used to analyze the ultrastructure of bacteria and host cells.

Main Results:

  • Rifampicin induced aggregation and condensation of ribosomes and disjunction of the cell-wall membranous system in B. melitensis.
  • Vacuoles containing rifampicin-damaged B. melitensis exhibited fusion with lysosomes in macrophages.
  • Vacuoles containing undamaged, viable B. melitensis showed impaired lysosomal fusion.

Conclusions:

  • Rifampicin causes significant ultrastructural damage to B. melitensis.
  • The drug enhances the susceptibility of B. melitensis to lysosomal degradation within macrophages.
  • These findings provide insights into the mechanism of action of rifampicin against B. melitensis infections.

Related Concept Videos